Your browser doesn't support javascript.
loading
Anti-human CD14 monoclonal antibody improves survival following sepsis induced by endotoxin, but not following polymicrobial infection.
Nakamura, Masaki; Takeuchi, Takashi; Shirakawa, Kamon; Furusako, Shoji.
Affiliation
  • Nakamura M; Discovery Research, Mochida Pharmaceutical Co., Ltd., Shizuoka, Japan. Electronic address: mnakamur@mochida.co.jp.
  • Takeuchi T; Discovery Research, Mochida Pharmaceutical Co., Ltd., Shizuoka, Japan.
  • Shirakawa K; Discovery Research, Mochida Pharmaceutical Co., Ltd., Shizuoka, Japan.
  • Furusako S; Discovery Research, Mochida Pharmaceutical Co., Ltd., Shizuoka, Japan.
Eur J Pharmacol ; 806: 18-24, 2017 Jul 05.
Article in En | MEDLINE | ID: mdl-28322834

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sepsis / Lipopolysaccharide Receptors / Endotoxins / Antibodies, Monoclonal Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Eur J Pharmacol Year: 2017 Document type: Article Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sepsis / Lipopolysaccharide Receptors / Endotoxins / Antibodies, Monoclonal Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Eur J Pharmacol Year: 2017 Document type: Article Country of publication: Netherlands